Preparation and evaluation of Nystatin loaded-solid-lipid nanoparticles for topical delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue SUPPL. 2, 2014, Pages 592-597

  Samein, Laith Hamza ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Nystatin; Release box behnken design; SLN

Indexed keywords

ANTIFUNGAL AGENT; CARBOPOL 940; DRUG CARRIER; NYSTATIN; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; SORBITAN STEARATE;

ARTICLE; CANDIDA ALBICANS; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; ENTRAPMENT EFFICIENCY; FLOW KINETICS; INFRARED SPECTROSCOPY; MELTING POINT; NANOEMULSION; PARTICLE SIZE; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOMETER; X RAY DIFFRACTION;

EID: 84896449398     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery, Int. J. Pharm. 184 (1999) 1-6.
2. Kreilgaard, Influence of microemulsions on cutaneous drug delivery, Adv. Drug Del. Rev. 54 (2002) S77-S98.
3. Denda, New strategies to improve skin barrier homeostatis, Adv. Drug Del. Rev. 54 suupl. 1 (2002) S123-S130.
4. G. B. S. Banker and C. T. Rodes, Modern Pharmacist, Vol. 40, 2nd ed., Marcel Dekker, New York 1979, pp. 263-273, 283, 286-287, 299-311.
5. P. Lemberger, A Hand Book of Non Prescription Drug, American Pharmaceutical Association, Washington 1973, pp. 161.
6. G. L. Wilkes, I. A. Brown and R. H. Wilnauer, CRC Crit. Rev. Bioeng. Aug 1973, pp. 453.
7. R. F. Rushmer, K. J. K. Buettner and J. M. Short, Odland Science, 154 (1966) 343.
8. B. M. Mithal and R. N. Saha, A Hand Book of Cosmetic, 1st ed., VallabhPrakashan; New Delhi 2003, pp. 11-17, 21-22, 37-38, 61-89, 90-93, 177, 214-215.
9. K. Jain, Controlled and Novel Drug Delivery, 1st ed., CBS Publishers and Distributors, Delhi 1997, pp. 100-106.
10. S. K. Singh, M. J. Durrani, I. K. Reddy and M. A. Khan, Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems, Pharmazie. 51 (1996) 741-744.
11. R. Panchagnula et al., Transdermal delivery of drugs, Int. J. Pharmacol. 29 (1997) 140-156.
12. V. R. Sinha and M. A. Kaur, Permeation enhancer for transdermal drug delivery, EastPharm. 38 (1997) 153.
13. R. H. Muller and J. S. Lucks, Azneistofftragerausfesten Lipidteilchen-feste Lipid Nanospharen (SLN), Eur. Pat. 0605497 1996.
14. R. H. Muller, W. Mehnert and E. B. Souto, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery. In. L. Bronaugh ed. Percutaneous Absorption, Marcel Dekker, New York 2005, pp. 719-738.
15. R. H. Muller, M. Radtke and S. A. Wissinng, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparation, Adv. Drug Del. Rev. 54 (2002) S131-S155.
16. R. H. Muller, K. Mader and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of art, Eur. J. Pharm. Biopharm. 50 (2000) 161-177.
17. B. Siekmann and K. Westesen, Submicron lipid suspensions (solid lipid nanoparticles) versus lipid nanoemulsions: similarities and differences, In. S. Benita ed. Submicron emulsions in Drug Targeting and Delivery, Harwood Academic Publishers. Amsterdam 1998, pp. 205-216.
18. R. H. Muller, M. Radtke and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs, Int. J. Pharm. 242 (2002);: 121-128.
19. R. H. Muller and S. A. Wissing, Lipopearls for topical delivery of active compounds and controlled release, In. M. J. Rathbone, J. Hadgraft, M. S. Roberts, eds. Modified-Release Drug Delivery Systems, Marcel Dekker, New York 2003, pp. 571-587.
20. W. Mehnert and K. Mader, Solid lipid nanoparticles-production, characterization and applications. Adv. Drug Del. Rev. 47 (2001) 165-196.
21. G. S. Sainini, API Textbook of medicine, Association of physician of India, 6th ed., McGraw Hill, New York 1999, pp. 1178-1180.
22. http: //www. doctorfungus. org/thedrugs/antif_pharm. htm.
23. R. W. Edwards, I. A. D. Bouchier, C. Haslett and E. R. Chilver, Davidson's principles and practice of medicine, 17th ed., Churchill Livingstone, Edinburgh 1991, pp. 142-147.
24. H. Mohan, Textbook of pathology, 3rd ed., Jaype Brothers Medical Publishers, New Delhi 1998, pp. 199-534.
25. J. B. Walter, Pathology of human disease, Lea and Febiger, London 1989, pp. 227-235.
26. R. M. N. Mac Sween and K. Whaley, Muir's Textbook of pathology, 13th ed., ELBS Publication, London 1995, pp. 331-335.
27. Nasseem, Formulation and evaluation of itraconazole via liquid crystal for topical delivery system, J. Pharm. Biomedical Analysis. 26 (3) (2001) 387-399.
28. Satturwar, J., N. Khandare and V. S. Nande, Niosomal delivery of ketoconazole, Indian Drug. 38 (2001) 620-624.
29. Agarwal and O. P. Katare, Miconazole nitrate-loaded topical liposomes, Pharm. Tech. 26 (2002) 48-60.
30. X. R. Qi, M. H. Liu, Y. Maitani and T. Nagai, Topical econazole delivery using liposomal gel, STP Pharm. Sci. 13 (2003) 241-245.
31. Charvalos, M. N. Tzatzarakis, F. V. Bambeke, P. M. Tulkens, A. M. Tsatsakis, G. N. Tzanakakis and M. P. Mingeot-Leclercq, water soluble Amphotericin B polyvinyl pyrrolidone complexes with maintained antifungal activity against Candida spp and Aspergillusspp and reduced haemolytic and cytotoxic effects, J. Antimicrobial Chemotherapy. 57(2) (2006) 236-244.
32. B. Souto and R. H. Muller, Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high pressure homogenization, J. Microencapsulation. 23(4) (2006) 377-388.
33. B. E. Elewski, W. Abramovits, S. Kempers, J. Schlessinger, T. Rosen, A. K. Gupta, S. Abraham and R. Rowell, A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions, J. Drug Derma. (2007).
34. V. V. Sanna, E. E. Gavini, M. M. Cossu, G. G. Rassu and P. P. Giunchedi, Solid lipid nanoparticles as carriers for the topical delivery of econazole nitrate: in vitro characterization, ex vivo and in vivo studied, J. Pharm. Pharmacol. 59 (8) (2007) 1057-64.